Intramural Needle Ablation for the Treatment of Refractory Ventricular Arrhythmias
Sponsor: Biosense Webster, Inc.
This NA trial investigates Ventricular Arrythmia and is currently completed. Biosense Webster, Inc. leads this study, which shows 13 recorded versions since 2017 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Nov 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2021 — Nov 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Apr 2021 — Jun 2021 [monthly]
Active Not Recruiting NA
▶ Show 8 earlier versions
-
Jan 2021 — Apr 2021 [monthly]
Active Not Recruiting NA
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Feb 2020 — Nov 2020 [monthly]
Recruiting NA
-
Jan 2020 — Feb 2020 [monthly]
Recruiting NA
-
Dec 2018 — Jan 2020 [monthly]
Recruiting NA
-
Jun 2018 — Dec 2018 [monthly]
Recruiting NA
-
Nov 2017 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Aug 2017 — Nov 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Biosense Webster, Inc.
- Vivek Reddy
For direct contact, visit the study record on ClinicalTrials.gov .